ABBV.NE
AbbVie Inc.
Cboe CACADEQUITY
DELAYED
Last price
36.93
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
36.93
Day high
36.93
Day low
36.93
Volume
100
Market cap
—
P/E (TTM)
—
52W range
23.68 – 36.93
Trailing performance
Returnvs SPY
1W
+5.97%
+7.0%
1M
+4.32%
+0.8%
3M
—
-2.6%
6M
—
-12.1%
YTD
+3.71%
-8.4%
1Y
—
-20.3%
3Y
—
-75.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on ABBV.NE open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $61.16B | $56.33B | $54.32B | $58.05B | +8.6% |
| Operating revenue | $61.16B | $56.33B | $54.32B | $58.05B | +8.6% |
| Cost of revenue | $18.20B | $16.90B | $20.41B | $17.41B | +7.7% |
| Gross profit | $42.96B | $39.43B | $33.90B | $40.64B | +8.9% |
| Research & development | $9.10B | $12.79B | $7.67B | $6.51B | -28.9% |
| Selling, general & admin | $14.01B | $14.75B | $12.87B | $15.26B | -5.0% |
| Total operating expense | $22.86B | $27.54B | $20.37B | $21.83B | -17.0% |
| Operating income | $20.09B | $11.89B | $13.54B | $18.81B | +68.9% |
| Net interest income | -$2.63B | -$2.16B | -$1.68B | -$2.04B | -21.6% |
| Pre-tax income | $6.60B | $3.72B | $6.25B | $13.48B | +77.5% |
| Tax provision | $2.36B | -$570.00M | $1.38B | $1.63B | +514.7% |
| Net income | $4.23B | $4.28B | $4.86B | $11.84B | -1.2% |
| Net income to common | $4.19B | $4.24B | $4.82B | $11.78B | -1.2% |
| Basic EPS | 0.25 | 0.26 | 0.29 | 0.71 | -2.2% |
| Diluted EPS | 0.25 | 0.25 | 0.29 | 0.70 | -0.8% |
| EBIT | $9.49B | $6.52B | $8.47B | $15.71B | +45.5% |
| EBITDA | $17.63B | $14.91B | $17.17B | $24.17B | +18.2% |
| Basic shares | 16.72B | 16.68B | 16.69B | 16.72B | +0.2% |
| Diluted shares | 16.75B | 16.75B | 16.75B | 16.80B | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $5.23B | $5.52B | $12.81B | $9.20B | -5.3% |
| Cash & short-term investments | $5.26B | $5.55B | $12.82B | $9.23B | -5.4% |
| Accounts receivable | $12.59B | $10.92B | $11.15B | $11.25B | +15.3% |
| Inventory | $4.95B | $4.18B | $4.10B | $3.58B | +18.4% |
| Total current assets | $29.06B | $25.58B | $33.00B | $28.46B | +13.6% |
| Property, plant & equipment | $5.63B | $5.13B | $4.99B | $4.93B | +9.6% |
| Goodwill & intangibles | $88.28B | $95.02B | $87.90B | $99.59B | -7.1% |
| Total assets | $133.96B | $135.16B | $134.71B | $138.81B | -0.9% |
| Total current liabilities | $43.29B | $38.75B | $37.84B | $29.54B | +11.7% |
| Current debt | $8.55B | $6.80B | $7.19B | $4.14B | +25.7% |
| Long-term debt | $58.94B | $60.34B | $52.19B | $59.13B | -2.3% |
| Total debt | $67.50B | $67.14B | $59.38B | $63.27B | +0.5% |
| Total liabilities | $137.19B | $131.80B | $124.31B | $121.52B | +4.1% |
| Retained earnings | -$15.49B | -$7.90B | -$1.00B | $4.78B | -96.1% |
| Shareholder equity | -$3.27B | $3.33B | $10.36B | $17.25B | -198.3% |
| Working capital | -$14.23B | -$13.17B | -$4.84B | -$1.07B | -8.1% |
| Net tangible assets | -$91.55B | -$91.70B | -$77.54B | -$82.34B | +0.2% |
| Shares issued | 1.84B | 1.83B | 1.82B | 1.81B | +0.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $4.23B | $4.29B | $4.87B | $11.85B | -1.2% |
| Depreciation & amortisation | $8.14B | $8.39B | $8.70B | $8.47B | -2.9% |
| Stock-based compensation | $955.00M | $911.00M | $747.00M | $671.00M | +4.8% |
| Change in working capital | -$2.36B | -$2.78B | $2.81B | -$94.00M | +15.1% |
| Operating cash flow | $19.03B | $18.81B | $22.84B | $24.94B | +1.2% |
| Capital expenditure | -$1.21B | -$974.00M | -$777.00M | -$695.00M | -24.6% |
| Investing cash flow | -$6.64B | -$20.82B | -$2.01B | -$623.00M | +68.1% |
| Share buybacks | -$980.00M | -$1.71B | -$1.97B | -$1.49B | +42.6% |
| Dividends paid | -$11.66B | -$11.03B | -$10.54B | -$10.04B | -5.7% |
| Financing cash flow | -$12.72B | -$5.21B | -$17.22B | -$24.80B | -144.2% |
| Free cash flow | $17.82B | $17.83B | $22.06B | $24.25B | -0.1% |
| End cash position | $5.23B | $5.52B | $12.81B | $9.20B | -5.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $16.99B | $15.00B | $16.62B | $15.78B | $15.42B | — | +13.3% |
| Operating revenue | $16.99B | $15.00B | $16.62B | $15.78B | $15.42B | — | +13.3% |
| Cost of revenue | $4.29B | $4.22B | $4.55B | $5.30B | $4.35B | — | +1.7% |
| Gross profit | $12.70B | $10.78B | $12.07B | $10.47B | $11.08B | — | +17.8% |
| Research & development | $2.34B | $2.47B | $2.58B | $2.32B | $2.13B | — | -5.2% |
| Selling, general & admin | $3.63B | $3.58B | $3.90B | $3.57B | $3.25B | — | +1.5% |
| Total operating expense | $5.98B | $6.05B | $6.26B | $5.89B | $5.36B | — | -1.2% |
| Operating income | $6.72B | $4.73B | $5.81B | $4.58B | $5.72B | — | +42.0% |
| Net interest income | -$679.00M | -$645.00M | -$655.00M | -$667.00M | -$678.00M | — | -5.3% |
| Pre-tax income | $4.28B | $1.04B | $2.67B | $714.00M | $1.55B | — | +311.7% |
| Tax provision | $662.00M | $342.00M | $853.00M | $526.00M | $613.00M | — | +93.6% |
| Net income | $3.61B | $695.00M | $1.82B | $186.00M | $938.00M | — | +419.9% |
| Net income to common | $3.60B | $685.00M | $1.81B | $176.00M | $928.00M | — | +425.7% |
| Basic EPS | 0.22 | 0.04 | 0.11 | 0.01 | 0.06 | — | +423.1% |
| Diluted EPS | 0.21 | 0.04 | 0.11 | — | 0.06 | 0.08 | +420.5% |
| EBIT | $5.02B | $1.76B | $3.38B | $1.45B | $2.29B | — | +186.1% |
| EBITDA | $6.91B | $3.69B | $5.37B | $3.52B | $4.34B | — | +87.1% |
| Basic shares | 16.72B | 16.72B | 16.70B | 16.72B | 16.71B | — | -0.1% |
| Diluted shares | 16.73B | 16.76B | 16.76B | — | 16.73B | 16.74B | -0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.57B | $9.39B | $5.23B | $5.63B | $6.47B | -30.1% |
| Cash & short-term investments | $6.57B | $9.39B | $5.26B | $5.67B | $6.47B | -30.1% |
| Accounts receivable | $13.82B | $12.48B | $12.59B | $12.77B | $12.64B | +10.8% |
| Inventory | $5.13B | $5.05B | $4.95B | $4.94B | $4.96B | +1.5% |
| Total current assets | $33.67B | $33.53B | $29.06B | $28.54B | $29.26B | +0.4% |
| Property, plant & equipment | $5.80B | $5.69B | $5.63B | $5.48B | $5.28B | +1.9% |
| Goodwill & intangibles | $84.66B | $86.44B | $88.28B | $89.94B | $92.67B | -2.1% |
| Total assets | $135.12B | $136.46B | $133.96B | $133.90B | $137.18B | -1.0% |
| Total current liabilities | $41.64B | $42.10B | $43.29B | $39.39B | $39.77B | -1.1% |
| Current debt | $8.34B | $8.33B | $8.55B | $5.77B | $7.52B | +0.2% |
| Long-term debt | $62.48B | $64.53B | $58.94B | $62.97B | $62.96B | -3.2% |
| Total debt | $70.82B | $72.86B | $67.50B | $68.74B | $70.48B | -2.8% |
| Total liabilities | $141.00B | $143.07B | $137.19B | $136.50B | $137.32B | -1.4% |
| Retained earnings | -$17.33B | -$17.87B | -$15.49B | -$14.23B | -$11.50B | +3.0% |
| Shareholder equity | -$5.93B | -$6.66B | -$3.27B | -$2.64B | -$183.00M | +10.8% |
| Working capital | -$7.97B | -$8.57B | -$14.23B | -$10.85B | -$10.51B | +7.0% |
| Net tangible assets | -$90.59B | -$93.10B | -$91.55B | -$92.58B | -$92.85B | +2.7% |
| Shares issued | 1.77B | 1.84B | 1.84B | 1.84B | 1.84B | -4.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $3.62B | $697.00M | $1.81B | $188.00M | $941.00M | +418.8% |
| Depreciation & amortisation | $1.88B | $1.94B | $1.99B | $2.06B | $2.05B | -2.7% |
| Stock-based compensation | $166.00M | $444.00M | $157.00M | $209.00M | $179.00M | -62.6% |
| Change in working capital | -$2.72B | -$1.92B | -$473.00M | $1.25B | -$562.00M | -41.6% |
| Operating cash flow | $3.44B | $3.83B | $5.22B | $7.02B | $5.15B | -10.3% |
| Capital expenditure | -$322.00M | -$265.00M | -$329.00M | -$381.00M | -$269.00M | -21.5% |
| Investing cash flow | -$1.20B | -$574.00M | -$1.46B | -$3.26B | -$1.18B | -108.5% |
| Share buybacks | -$9.00M | -$1.49B | -$3.00M | -$4.00M | -$12.00M | +99.4% |
| Dividends paid | -$3.07B | -$3.09B | -$2.91B | -$2.91B | -$2.91B | +0.5% |
| Financing cash flow | -$5.05B | $919.00M | -$4.17B | -$4.59B | -$2.71B | -649.9% |
| Free cash flow | $3.11B | $3.56B | $4.89B | $6.64B | $4.88B | -12.6% |
| End cash position | $6.57B | $9.39B | $5.23B | $5.63B | $6.47B | -30.1% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
35.44
+4.20% from price
SMA 20
35.38
+4.41% from price
SMA 50
—
—
SMA 100
—
—
SMA 200
—
—
EMA 12
35.72
+3.40% from price
EMA 26
—
—
EMA 50
—
—
RSI (14)
61.7
Neutral
MACD (12,26,9)
—
Hist —
ATR (14)
0.54
1.45% of price
Realised vol 30D
—
Annualised
Bollinger upper
37.42
20, 2σ
Bollinger lower
33.34
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
—
—
Correlation to SPY
—
—
Realised vol 30D
—
Annualised
Market vol 1Y
—
SPY, annualised
Max drawdown 1Y
-8.1%
Peak to trough
Max drawdown 5Y
-8.1%
Peak to trough
ATR 14
0.54
1.45% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Archer Aviation Makes Bigger Bet on Los Angeles
GuruFocus.com · 1m ago
Verizon Turns to Google for Its Next AI Push
GuruFocus.com · 2m ago
Walmart's $25 Fashion Bet Takes Aim at Amazon
GuruFocus.com · 4m ago
Nancy Pelosi Disclosure Reveals Two Fresh AI Stock Bets
GuruFocus.com · 6m ago
Q2 Earnings Highlights: ICU Medical (NASDAQ:ICUI) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
StockStory · 7m ago
Google Is Turning Gemini Into a Website Builder
GuruFocus.com · 7m ago
Dream of owning a home is slipping away for young Americans
TheStreet · 7m ago
Centurion Executes Letter of Intent to Acquire the Brothers Gold Project, Suriname
TMX Newsfile · 8m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.